441 related articles for article (PubMed ID: 35867573)
21. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
23. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
24. ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Lyu Y; Nakano K; Davis RR; Tepper CG; Campbell M; Izumiya Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835494
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
Sun R; Liang D; Gao Y; Lan K
J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
Toth Z; Smindak RJ; Papp B
Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
[TBL] [Abstract][Full Text] [Related]
27. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
29. Caspase-Mediated Cleavage of the Transcription Factor Sp3: Possible Relevance to Cancer and the Lytic Cycle of Kaposi's Sarcoma-Associated Herpesvirus.
Chen LY; Chen LW; Hung CH; Lin CL; Wang SS; Chang PJ
Microbiol Spectr; 2022 Feb; 10(1):e0146421. PubMed ID: 35019687
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.
Lu F; Stedman W; Yousef M; Renne R; Lieberman PM
J Virol; 2010 Mar; 84(6):2697-706. PubMed ID: 20071580
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of KSHV lytic reactivation.
Purushothaman P; Uppal T; Verma SC
Viruses; 2015 Jan; 7(1):116-53. PubMed ID: 25594835
[TBL] [Abstract][Full Text] [Related]
32. KSHV RTA antagonizes SMC5/6 complex-induced viral chromatin compaction by hijacking the ubiquitin-proteasome system.
Han C; Zhang D; Gui C; Huang L; Chang S; Dong L; Bai L; Wu S; Lan K
PLoS Pathog; 2022 Aug; 18(8):e1010744. PubMed ID: 35914008
[TBL] [Abstract][Full Text] [Related]
33. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Toth Z; Brulois KF; Wong LY; Lee HR; Chung B; Jung JU
J Virol; 2012 Sep; 86(18):9696-707. PubMed ID: 22740393
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
35. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
36. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.
Jha HC; Lu J; Verma SC; Banerjee S; Mehta D; Robertson ES
mBio; 2014 Dec; 5(6):. PubMed ID: 25516617
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
40. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
